BLACKBIRD DAMAGE AND CONTROL--AN INFORMAL SEMINAR

The object is to hash over a few problems as we see them on this red-winged blackbird situation. I'm Mel Dyer, University of Guelph, Guelph, Ontario. Around the table are Tom Stockdale, Extension Wildlife Specialist, Ohio Cooperative Extension Service, Columbus; Maurice Giltz, Ohio Agriculture Research and Development Center, Wooster, Ohio; Joe Halusky, U.S. Fish and Wildlife Service, Columbus, Ohio; Daniel Stiles, U.S. Fish and Wildlife Service, Washington, D.C.; Paul Rodeheffer, U.S. Fish and Wildlife Service, Columbus, Ohio; Brian Hall, Blackbird Research Project, University of Guelph, Guelph, Ontario; George Cornwell, Virginia Polytechnic Insti¬tute, Blacksburg, Va.; Dick Warren, Peavey Grain Company, Minneapolis, Minn.; Bob Fringer, N.J. Department of Agriculture, Trenton, N.J.; Charles Stone, U.S. Fish and Wildlife Service, Columbus, Ohio; Larry Holcomb, Ohio Agricultural Research and Development Center, Wooster, Ohio; Doug Slack, Ohio Agricultural Research and Development Center, Wooster, Ohio; Charles Wagg, N.J. Department of Agriculture, Trenton, N.J.; Dick Smith, U.S. Fish and Wildlife Service, Columbus, Ohio; and Jim Caslick, U.S. Fish and Wildlife Service, Gainesville, Fla. As I see the situation, as a director of a red-winged blackbird research project, we have a problem which has been defined in human terms concerning a natural animal population.

EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists

The European Position Paper on Rhinosinusitis and Nasal Polyps 2012 is the update of similar evidence based position papers published in 2005 and 2007. The document contains chapters on definitions and classification, we now also propose definitions for 'difficult to treat' rhinosinusitis, control of disease and better definitions for rhinosinusitis in children. More emphasis is placed on the diagnosis and treatment of acute rhinosinusitis. Throughout the document the terms chronic rhinosinusitis without nasal polyps (CRSsNP) and chronic rhinosinusitis with nasal polyps (CRSwNP) are used to further point out differences in pathophysiology and treatment of these two entities. There are extensive chapters on epidemiology and predisposing factors, inflammatory mechanisms, (differential) diagnosis of facial pain, genetics, cystic fibrosis, aspirin exacerbated respiratory disease, immunodeficiencies, allergic fungal rhinosinusitis and the relationship between the upper and lower airways. The chapters on paediatric acute and chronic rhinosinusitis are totally rewritten. Last but not least all available evidence for management of acute rhinosinusitis and chronic rhinosinusitis with or without nasal polyps in adults and children is analyzed and presented and management schemes based on the evidence are proposed. This executive summary for otorhinolaryngologists focuses on the most important changes and issues for otorhinolaryngologists.

The impact of medical education and networking on the outcome of leukemia treatment in developing countries. The experience of International Consortium on Acute Promyelocytic Leukemia (IC-APL)

Objectives: Several clinical trials conducted in Europe and US reported favorable outcomes of patients with APL treated with the combination of all trans retinoic acid (ATRA) and anthracyclines. Nevertheless, the results observed in developing countries with the same regimen was poorer, mainly due to high early mortality mainly due bleeding. The International Consortium on Acute Promyelocytic Leukemia (IC-APL) is an initiative of the International Members Committee of the ASH and the project aims to reduce this gap through the establishment of international network, which was launched in Brazil, Mexico and Uruguay. Methods: The IC-APL treatment protocol is similar to the PETHEMA 2005, but changing idarubicin to daunorubicin. All patients with a suspected diagnosis of APL were immediately started on ATRA, while bone marrow samples were shipped to a national central lab where genetic verification of the diagnosis was performed. The immunofluorescence using an anti-PML antibody allowed a rapid confirmation of the diagnosis and, the importance of supportive measures was reinforced. Results: The interim analysis of 97 patients enrolled in the IC-APL protocol showed that complete remission (CR) rate was 83% and the 2-year overall survival and disease-free survival were 80% and 90%, respectively. Of note, the early mortality rate was reduced to 7.5%. Discussion: The results of IC-APL demonstrate the impact of educational programs and networking on the improvement of the leukemia treatment outcome in developing countries.

La concezione epistemica dell'analiticità: un dibattito in corso

Il lavoro è una riflessione sugli sviluppi della nozione di definizione nel recente dibattito sull'analiticità. La rinascita di questa discussione, dopo le critiche di Quine e un conseguente primo abbandono della concezione convenzionalista carnapiana ha come conseguenza una nuova concezione epistemica dell'analiticità. Nella maggior parte dei casi le nuove teorie epistemiche, tra le quali quelle di Bob Hale e Crispin Wright (Implicit Definition and the A priori, 2001) e Paul Boghossian (Analyticity, 1997; Epistemic analyticity, a defence, 2002, Blind reasoning, 2003, Is Meaning Normative ?, 2005) presentano il comune carattere di intendere la conoscenza a priori nella forma di una definizione implicita (Paul Horwich, Stipulation, Meaning, and Apriority, 2001). Ma una seconda linea di obiezioni facenti capo dapprima a Horwich, e in seguito agli stessi Hale e Wright, mettono in evidenza rispettivamente due difficoltà per la definizione corrispondenti alle questioni dell'arroganza epistemica e dell'accettazione (o della stipulazione) di una definizione implicita. Da questo presupposto nascono diversi tentativi di risposta. Da un lato, una concezione della definizione, nella teoria di Hale e Wright, secondo la quale essa appare come un principio di astrazione, dall'altro una nozione della definizione come definizione implicita, che si richiama alla concezione di P. Boghossian. In quest'ultima, la definizione implicita è data nella forma di un condizionale linguistico (EA, 2002; BR, 2003), ottenuto mediante una fattorizzazione della teoria costruita sul modello carnapiano per i termini teorici delle teorie empiriche. Un'analisi attenta del lavoro di Rudolf Carnap (Philosophical foundations of Physics, 1966), mostra che la strategia di scomposizione rappresenta una strada possibile per una nozione di analiticità adeguata ai termini teorici. La strategia carnapiana si colloca, infatti, nell'ambito di un tentativo di elaborazione di una nozione di analiticità che tiene conto degli aspetti induttivi delle teorie empiriche

"Canzoni per l'America: gli Stati Uniti e le sue genti attraverso la musica folk"

Riassunto Il nostro viaggio attraverso la musica folk americana partirà dal un racconto della Grande Depressione, dello stato di indigenza nel quale versava la maggior parte della popolazione e attraverso le vicende e le canzoni del nonno della canzone di protesta: Woody Guthrie. Sottolineeremo come egli abbia influenzato successivamente tutta una serie di cantautori che si formarono con lui, attraverso i suoi scritti o i suoi pezzi. Vedremo dunque come un altro grande musicista, Pete Seeger lottò più volte contro la censura per dare risonanza a tante battaglie altrimenti inascoltate, come i movimenti per i diritti civili degli afroamericani e per la pace. Con le canzoni di Bob Dylan analizzeremo i movimenti giovanili e pacifisti contro la guerra nel Vietnam e i fermenti della beat generation. Considereremo con Bruce Springsteen i nuovi diseredati della recessione economica, la nuova ondata di nazionalismi, le censure successive agli attentati dell’ 11 Settembre 2001 e il nuovo ordine mondiale. La musica folk continuerà dunque a vivere grazie alla comunità che la rende viva e la fa circolare, ma soprattutto, grazie al passaggio di testimone tra i grandi artisti che l’hanno resa concretamente la voce dell’America.

Accessible information in a two-qubit system through the quantum steering ellipsoids formalism

Capire come ottenere l'informazione accessibile, cioè quanta informazione classica si può estrarre da un processo quantistico, è una delle questioni più intricate e affascinanti nell'ambito della teoria dell'informazione quantistica. Nonostante l'importanza della nozione di informazione accessibile non esistono metodi generali per poterla calcolare, esistono soltanto dei limiti, i più famosi dei quali sono il limite superiore di Holevo e il limite inferiore di Josza-Robb-Wootters. La seguente tesi fa riferimento a un processo che coinvolge due parti, Alice e Bob, che condividono due qubits. Si considera il caso in cui Bob effettua misure binarie sul suo qubit e quindi indirizza lo stato del qubit di Alice in due possibili stati. L'obiettivo di Alice è effettuare la misura ottimale nell'ottica di decretare in quale dei due stati si trova il suo qubit. Lo strumento scelto per studiare questo processo va sotto il nome di 'quantum steering ellipsoids formalism'. Esso afferma che lo stato di un sistema di due qubit può essere descritto dai vettori di Bloch di Alice e Bob e da un ellissoide nella sfera di Bloch di Alice generato da tutte le possibili misure di Bob. Tra tutti gli stati descritti da ellissoidi ce ne sono alcuni che manifestano particolari proprietà, per esempio gli stati di massimo volume. Considerando stati di massimo volume e misure binarie si è riuscito a trovare un limite inferiore all'informazione accessibile per un sistema di due qubit migliore del limite inferiore di Josza-Robb-Wootters. Un altro risultato notevole e inaspettato è che l'intuitiva e giustificata relazione 'distanza tra i punti nell'ellissoide - mutua informazione' non vale quando si confrontano coppie di punti ''vicine'' tra loro e lontane dai più distanti.

Flugzeuggetragene in-situ Messungen zur Eis- und Flüssigphase troposphärischer Wolken

Die Mikrophysik in Wolken bestimmt deren Strahlungseigenschaften und beeinflusst somit auch den Strahlungshaushalt des Planeten Erde. Aus diesem Grund werden im Rahmen der vorliegenden Arbeit die mikrophysikalischen Charakteristika von Cirrus-Wolken sowie von arktischen Grenzschicht-Wolken behandelt. Die Untersuchung dieser Wolken wurde mithilfe verschiedener Instrumente verwirklicht, welche Partikel in einem Durchmesserbereich von 250nm bis zu 6.4mm vermessen und an Forschungsflugzeugen montiert werden. Ein Instrumentenvergleich bestätigt, dass innerhalb der Bereiche in denen sich die Messungen dieser Instrumente überlappen, die auftretenden Diskrepanzen als sehr gering einzustufen sind. Das vorrangig verwendete Instrument trägt die Bezeichnung CCP (Cloud Combination Probe) und ist eine Kombination aus einem Instrument, das Wolkenpartikel anhand von vorwärts-gerichtetem Streulicht detektiert und einem weiteren, das zweidimensionale Schattenbilder einzelner Wolkenpartikel aufzeichnet. Die Untersuchung von Cirrus-Wolken erfolgt mittels Daten der AIRTOSS-ICE (AIRcraft TOwed Sensor Shuttle - Inhomogeneous Cirrus Experiment) Kampagne, welche im Jahr 2013 über der deutschen Nord- und Ostsee stattfand. Parameter wie Partikeldurchmesser, Partikelanzahlkonzentration, Partikelform, Eiswassergehalt, Wolkenhöhe und Wolkendicke der detektierten Cirrus-Wolken werden bestimmt und im Kontext des aktuellen Wissenstandes diskutiert. Des Weiteren wird eine beprobte Cirrus-Wolke im Detail analysiert, welche den typischen Entwicklungsprozess und die vertikale Struktur dieser Wolkengattung widerspiegelt. Arktische Grenzschicht-Wolken werden anhand von Daten untersucht, die während der VERDI (VERtical Distribution of Ice in Arctic Clouds) Kampagne im Jahr 2012 über der kanadischen Beaufortsee aufgezeichnet wurden. Diese Messkampagne fand im Frühling statt, um die Entwicklung von Eis-Wolken über Mischphasen-Wolken bis hin zu Flüssigwasser-Wolken zu beobachten. Unter bestimmten atmosphärischen Bedingungen tritt innerhalb von Mischphasen-Wolken der sogenannte Wegener-Bergeron-Findeisen Prozess auf, bei dem Flüssigwassertropfen zugunsten von Eispartikeln verdampfen. Es wird bestätigt, dass dieser Prozess anhand von mikrophysikalischen Messungen, insbesondere den daraus resultierenden Größenverteilungen, nachweisbar ist. Darüber hinaus wird eine arktische Flüssigwasser-Wolke im Detail untersucht, welche im Inneren das Auftreten von monomodalen Tröpfchen-Größenverteilungen zeigt. Mit zunehmender Höhe wachsen die Tropfen an und die Maxima der Größenverteilungen verschieben sich hin zu größeren Durchmessern. Dahingegen findet im oberen Übergangsbereich dieser Flüssigwasser-Wolke, zwischen Wolke und freier Atmosphäre, ein Wechsel von monomodalen zu bimodalen Tröpfchen-Größenverteilungen statt. Diese weisen eine Mode 1 mit einem Tropfendurchmesser von 20μm und eine Mode 2 mit einem Tropfendurchmesser von 10μm auf. Das dieses Phänomen eventuell typisch für arktische Flüssigwasser-Wolken ist, zeigen an dem Datensatz durchgeführte Analysen. Mögliche Entstehungsprozesse der zweiten Mode können durch Kondensation von Wasserdampf auf eingetragenen Aerosolpartikeln, die aus einer Luftschicht oberhalb der Wolke stammen oder durch Wirbel, welche trockene Luftmassen in die Wolke induzieren und Verdampfungsprozesse von Wolkentröpfchen hervorrufen, erklärt werden. Unter Verwendung einer direkten numerischen Simulation wird gezeigt, dass die Einmischung von trockenen Luftmassen in den Übergangsbereich der Wolke am wahrscheinlichsten die Ausbildung von Mode 2 verursacht.

Gemtuzumab ozogamicin as postremission treatment in AML at 60 years of age or more: results of a multicenter phase 3 study

In older patients with acute myeloid leukemia (AML), the prevention of relapse has remained one of the major therapeutic challenges, with more than 75% relapses after complete remission. The anti-CD33 immunotoxin conjugate gemtuzumab ozogamicin (GO) has shown antileukemic remission induction activity in patients with relapsed AML. Patients with AML or refractory anemia with excess blasts in first complete remission attained after intensive induction chemotherapy were randomized between 3 cycles of GO (6 mg/m(2) every 4 weeks) or no postremission therapy (control) to assess whether GO would improve outcome. The 2 treatment groups (113 patients receiving GO vs 119 control patients) were comparable with regard to age (60-78 years, median 67 years), performance status, and cytogenetics. A total of 110 of 113 received at least 1 cycle of GO, and 65 of 113 patients completed the 3 cycles. Premature discontinuation was mainly attributable to incomplete hematologic recovery or intercurrent relapse. Median time to recovery of platelets 50 x 10(9)/L and neutrophils 0.5 x 10(9)/L after GO was 14 days and 20 days. Nonhematologic toxicities were mild overall, but there was 1 toxic death caused by liver failure. There were no significant differences between both treatment groups with regard to relapse probabilities, nonrelapse mortality, overall survival, or disease-free survival (17% vs 16% at 5 years). Postremission treatment with GO in older AML patients does not provide benefits regarding any clinical end points. The HOVON-43 study is registered at The Netherlands Trial Registry (number NTR212) and at http://www.controlled-trials.com as ISRCTN77039377.

Heavy metal cations permeate the TRPV6 epithelial cation channel

TRPV6 belongs to the vanilloid family of the transient receptor potential channel (TRP) superfamily. This calcium-selective channel is highly expressed in the duodenum and the placenta, being responsible for calcium absorption in the body and fetus. Previous observations have suggested that TRPV6 is not only permeable to calcium but also to other divalent cations in epithelial tissues. In this study, we tested whether TRPV6 is indeed also permeable to cations such as zinc and cadmium. We found that the basal intracellular calcium concentration was higher in HEK293 cells transfected with hTRPV6 than in non-transfected cells, and that this difference almost disappeared in nominally calcium-free solution. Live cell imaging experiments with Fura-2 and NewPort Green DCF showed that overexpression of human TRPV6 increased the permeability for Ca(2+), Ba(2+), Sr(2+), Mn(2+), Zn(2+), Cd(2+), and interestingly also for La(3+) and Gd(3+). These results were confirmed using the patch clamp technique. (45)Ca uptake experiments showed that cadmium, lanthanum and gadolinium were also highly efficient inhibitors of TRPV6-mediated calcium influx at higher micromolar concentrations. Our results suggest that TRPV6 is not only involved in calcium transport but also in the transport of other divalent cations, including heavy metal ions, which may have toxicological implications.

Favorable effect of priming with granulocyte colony-stimulating factor in remission induction of acute myeloid leukemia restricted to dose-escalation of cytarabine

The clinical value of chemotherapy sensitization of acute myeloid leukemia (AML) with G-CSF priming has remained controversial. Cytarabine is a key constituent of remission induction chemotherapy. The effect of G-CSF priming has not been investigated in relationship with variable dose levels of cytarabine. We randomized 917 AML patients to receive G-CSF (456 patients) or no G-CSF (461 patients) at the days of chemotherapy. In the initial part of the study, 406 patients were also randomized between 2 cytarabine regimens comparing conventional-dose (199 patients) versus escalated-dose (207 patients) cytarabine in cycles 1 and 2. We found that patients after induction chemotherapy plus G-CSF had similar overall survival (43% vs 40%, P = .88), event-free survival (37% vs 31%, P = .29), and relapse rates (34% vs 36%, P = .77) at 5 years as those not receiving G-CSF. However, patients treated with the escalated-dose cytarabine regimen benefited from G-CSF priming, with improved event-free survival (P = .01) and overall survival (P = .003), compared with patients without G-CSF undergoing escalated-dose cytarabine treatment. A significant survival advantage of sensitizing AML for chemotherapy with G-CSF was not apparent in the entire study group, but it was seen in patients treated with escalated-dose cytarabine during remission induction. The HOVON-42 study is registered under The Netherlands Trial Registry (www.trialregister.nl) as #NTR230.

Cytarabine dose for acute myeloid leukemia

Cytarabine (ara-C) is an important drug in the treatment of acute myeloid leukemia (AML). High-dose cytarabine (2000 to 3000 mg per square meter of body-surface area) is toxic but results in higher rates of relapse-free survival than does the conventional dose of 100 to 400 mg per square meter. Intermediate dose levels have not been thoroughly evaluated.

PU.1 is linking the glycolytic enzyme HK3 in neutrophil differentiation and survival of APL cells

The transcription factor PU.1 is a master regulator of myeloid differentiation and function. On the other hand, only scarce information is available on PU.1-regulated genes involved in cell survival. We now identified the glycolytic enzyme hexokinase 3 (HK3), a gene with cytoprotective functions, as transcriptional target of PU.1. Interestingly, HK3 expression is highly associated with the myeloid lineage and was significantly decreased in acute myeloid leukemia patients compared with normal granulocytes. Moreover, HK3 expression was significantly lower in acute promyelocytic leukemia (APL) compared with non-APL patient samples. In line with the observations in primary APL patient samples, we observed significantly higher HK3 expression during neutrophil differentiation of APL cell lines. Moreover, knocking down PU.1 impaired HK3 induction during neutrophil differentiation. In vivo binding of PU.1 and PML-RARA to the HK3 promoter was found, and PML-RARA attenuated PU.1 activation of the HK3 promoter. Next, inhibiting HK3 in APL cell lines resulted in significantly reduced neutrophil differentiation and viability compared with control cells. Our findings strongly suggest that HK3 is: (1) directly activated by PU.1, (2) repressed by PML-RARA, and (3) functionally involved in neutrophil differentiation and cell viability of APL cells.

Autologous peripheral blood stem cell transplantation for acute myeloid leukemia

We report the results of a prospective, randomized phase 3 trial evaluating autologous peripheral blood stem cell transplantation (ASCT) versus intensive consolidation chemotherapy in newly diagnosed AML patients in complete remission (CR1). Patients with AML (16-60 years) in CR1 after 2 cycles of intensive chemotherapy and not eligible for allogeneic SCT were randomized between intensive chemotherapy with etoposide and mitoxantrone or ASCT ater high-dose cyclophosphamide and busulfan. Of patients randomized (chemotherapy, n = 259; ASCT, n = 258), more than 90% received their assigned treatment. The 2 groups were comparable with regard to prognostic factors. The ASCT group showed a markedly reduced relapse rate (58% vs 70%, P = .02) and better relapse-free survival at 5 years (38% vs 29%, P = .065, hazard ratio = 0.82; 95% confidence interval, 0.66-1.1) with nonrelapse mortality of 4% versus 1% in the chemotherapy arm (P = .02). Overall survival was similar (44% vs 41% at 5 years, P = .86) because of more opportunities for salvage with second-line chemotherapy and stem cell transplantation in patients relapsing on the chemotherapy arm. This large study shows a relapse advantage for ASCT as postremission therapy but similar survival because more relapsing patients on the chemotherapy arm were salvaged with a late transplantation for relapse. This trial is registered at www.trialregister.nl as #NTR230 and #NTR291.